106 Days
Source:
الصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
106 Daysالصحة والعلوم الشرق الأوسط
Source: الصحة والعلوم الشرق الأوسط
106 DaysReady to play
Ready to play
An international research team has developed an innovative therapeutic approach for tuberculosis that relies on high-precision molecular simulation techniques to design drug compounds targeting the enzyme CYP3A4, which is responsible for drug metabolism in the liver. This method represents a significant step toward improving the effectiveness of tuberculosis treatments and reducing their side effects, especially with the emergence of drug-resistant strains, by modifying drug compounds to increase their binding affinity to the enzyme and enhance their pharmacological properties. It is anticipated that this approach will contribute to strengthening patient responses and decreasing the likelihood of future drug resistance.
Notice: This Is an AI-Generated Summary
Comments (0)